Generally, you may be a good candidate for GLP-1 therapy if: You have a body mass index (BMI) that falls within a certain range, typically 27 or higher with a weight-related health condition, or 30 or higher without one
Sustained Fullness: Slows stomach emptying to help you feel full longer, which can reduce overall calorie intake
Although some patients may endure severe heartburn, most people tend to experience mild to moderate symptoms, says Sazan Sylejmani, Pharm.D., owner and pharmacy manager at Westmont Pharmacy in Illinois
Rosenstock predicts that orforglipron and other similar small-molecule pills will eventually form the backbone of mainstream diabetes treatment, a role played today by the older glucose-lowering drug metformin: I can see these molecules as a first-line therapy, he says, prescribed to patients from day one. New Treatment Targets Drug developers are also racing to devise medications that drive even greater weight loss and offer more comprehensive overall health benefits, primarily by testing new agents that affect more than just the GLP-1 hormone receptor